Recro Pharma (NASDAQ:REPH) Earnings Information
Recro Pharma last released its earnings data on February 26th, 2021. The specialty pharmaceutical company reported ($0.48) EPS for the quarter, missing analysts' consensus estimates of ($0.26) by $0.22. The firm had revenue of $9.91 million for the quarter. Recro Pharma has generated $0.20 earnings per share over the last year and currently has a price-to-earnings ratio of 15.2. Recro Pharma has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 10th, 2021 based off prior year's report dates.
Recro Pharma Earnings Estimates and Actuals by Quarter
The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.
Recro Pharma (NASDAQ:REPH) Earnings Estimates
2021 EPS Consensus Estimate: $0.18
Recro Pharma (NASDAQ REPH) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)